Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis

NCT06630403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-10-08

No results posted yet for this study

Summary

The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.

Conditions

Interventions

OTHER

Demographic Data

Demographic data (age, height, weight, BMI) will be collected verbally through an assessment form.

OTHER

Disease History

The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.

OTHER

Pulmonary Function Test

Pulmonary Function Test will be performed with a spirometer.

OTHER

Reaction Time

Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.

OTHER

Functional Capacity

Functional capacity will be evaluated with 6 minute walk test

OTHER

Dyspnea Perception

Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea

OTHER

Quality of Life

Quality of life will be assessed with the "Quality of Life Scale for Children\"

OTHER

Fear of movement

Fear of movement will be evaluated with Tampa Kinesiophobia Scale

OTHER

Ability of Motor Imagery

Motor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery

OTHER

Cognitive Functions

Cognitive functions will be assessed with Trail Making Test and Stroop Test

Sponsors & Collaborators

  • Health Institutes of Turkey

    collaborator OTHER_GOV
  • Atlas University

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630403 on ClinicalTrials.gov